Literature DB >> 21980068

CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.

Meng-Rui Lee1, Aristine Cheng, Yi-Chieh Lee, Ching-Yao Yang, Chih-Cheng Lai, Yu-Tsung Huang, Chao-Chi Ho, Hao-Chien Wang, Chong-Jen Yu, Po-Ren Hsueh.   

Abstract

OBJECTIVES: CNS infections caused by non-tuberculous mycobacteria (NTM) are rare and only three cases of CNS infections due to Mycobacterium abscessus complex have been reported.
METHODS: We searched the Mycobacteriology Database of the National Taiwan University Hospital and identified patients with CNS infections due to NTM.
RESULTS: A total of 15 patients, namely 4 HIV-seropositive patients and 11 HIV-seronegative patients, with CNS infections caused by NTM were identified during 2000-10. All of the HIV-seropositive patients had disseminated Mycobacterium avium complex infections. Among the 11 HIV-seronegative patients, NTM CNS infections were due to M. abscessus complex in 8 patients, M. avium complex in 2 patients and Mycobacterium kansasii in 1 patient. All the six preserved M. abscessus complex isolates were confirmed to be Mycobacterium massiliense by erm(41) PCR and 23S rRNA gene sequence analysis. Among the eight patients with infections due to M. abscessus complex, three had otolaryngological diseases, four had received neurosurgery and one had disseminated disease. Five patients received surgical debridement or intracranial device removal and three patients died of M. abscessus complex CNS infection. Among the five patients who survived, all received clarithromycin-based combination therapy with a median duration of 12 months and four received surgical intervention. All six isolates available for drug susceptibility testing showed uniform susceptibility to clarithromycin and five were susceptible to amikacin.
CONCLUSIONS: Our study revealed that M. abscessus complex isolates, particularly M. massiliense, should be considered potential pathogens causing CNS infections. Long-duration clarithromycin-based combination therapy plus surgical intervention may provide the best chance of cure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21980068     DOI: 10.1093/jac/dkr420

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation.

Authors:  Audrey Bernut; Jean-Louis Herrmann; Karima Kissa; Jean-François Dubremetz; Jean-Louis Gaillard; Georges Lutfalla; Laurent Kremer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

2.  Unusual cause of progressively impaired cognitive function: Mycobacterium avium complex meningoencephalitis.

Authors:  Yuji Okazaki; Yusuke Higashi
Journal:  BMJ Case Rep       Date:  2019-04-03

Review 3.  Mycobacterium abscessus ventriculoperitoneal shunt infection and review of the literature.

Authors:  Jose A Montero; Sally F Alrabaa; Todd S Wills
Journal:  Infection       Date:  2015-07-07       Impact factor: 3.553

4.  Mycobacterium abscessus WhiB7 Regulates a Species-Specific Repertoire of Genes To Confer Extreme Antibiotic Resistance.

Authors:  Kelley Hurst-Hess; Paulami Rudra; Pallavi Ghosh
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii).

Authors:  Meng-Rui Lee; Hsih-Yeh Tsai; Aristine Cheng; Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Sheng-Kai Liang; Li-Na Lee; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

Review 6.  Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature.

Authors:  Francesca Giovannenze; Vito Stifano; Giancarlo Scoppettuolo; Fernando Damiano; Federico Pallavicini; Giovanni Delogu; Ivana Palucci; Alessandro Rapisarda; Cosimo Sturdà; Angelo Pompucci
Journal:  Infection       Date:  2018-04-23       Impact factor: 3.553

7.  In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system.

Authors:  Audrey Bernut; Vincent Le Moigne; Tiffany Lesne; Georges Lutfalla; Jean-Louis Herrmann; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

8.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry can accurately differentiate between Mycobacterium masilliense (M. abscessus subspecies bolletti) and M. abscessus (sensu stricto).

Authors:  Shih-Hua Teng; Chung-Ming Chen; Meng-Rui Lee; Tai-Fen Lee; Kun-Yi Chien; Lee-Jene Teng; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

9.  In Vitro Evaluation of Povidone-Iodine and Chlorhexidine against Outbreak and Nonoutbreak Strains of Mycobacterium abscessus Using Standard Quantitative Suspension and Carrier Testing.

Authors:  Aristine Cheng; Hsin-Yun Sun; Yi-Tzu Tsai; Un-In Wu; Yu-Chung Chuang; Jann-Tay Wang; Wang-Huei Sheng; Po-Ren Hsueh; Yee-Chun Chen; Shan-Chwen Chang
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

10.  Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos.

Authors:  Audrey Bernut; Christian Dupont; Alain Sahuquet; Jean-Louis Herrmann; Georges Lutfalla; Laurent Kremer
Journal:  J Vis Exp       Date:  2015-09-09       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.